|

NZD/USD tests 0.6900 amid vaccine driven risk on FX market flows

  • NZD is one of the best performing G10 currencies on Monday, amid a risk-on tone to FX market trade.
  • NZD/USD is currently testing the psychological 0.6900 level as US dollar weakness gains traction.

NZD/USD is enjoying solid gains on Monday, with the pair up over 50 pips or 0.8% on the day, and looking to take out 0.6900 to the upside.

Risk sensitive NZD enjoys vaccine driven boost

Risk assets received another shot in the arm on Monday morning, almost exactly one week following Pfizer and BioNtech's positive vaccine announcement last Monday; Moderna released the results of their Phase 3 trial and their vaccine might be even better. Firstly, it has a slightly higher efficacy rate at 94.5% (Pfizer/BioNtech’s vaccine was about 90%) and secondly, it can be stored at refrigerator temperatures (Pfizer/BioNtech’s vaccine must be kept frozen, which presents a key logistic/distributional challenge).

Thus, financial markets have again cheered; the S&P 500 currently trades with gains in excess of 1.0%, while over in Europe, the Stoxx 600 closed up by around 1.2%. Meanwhile, crude oil markets (front-month Brent and WTI futures) are up over 3% and US yields have again moved higher, with the yield curve steepening.

FX markets are also feeling the positive vibes; leading the G10 FX performance table are the risk-sensitive quintuplet NOK, NZD, AUD, SEK and CAD in that order. NOK is up nearly 1% vs USD, the antipodes roughly 0.7% and SEK and CAD roughly 0.4%. Meanwhile, JPY, CHF, GBP, EUR and USD are the worst G10 FX performers on the day, all trading pretty much flat vs each other.

Amid a lack of any notable domestic New Zealand events (there is no important data or RBNZ events or speakers), NZD looks set to continue to trade as a function of broader risk appetite. There is a chance that the kiwi might be affected by a busy domestic schedule of events across the Tasman Sea; out of Australia this week there are a few important RBA speakers as well as crucial retail sales and labour market data for October that could shift AUD (and thus also potentially NZD in sympathy).

Turning to the USD side of the equation, as well as the upturn in risk sentiment, USD is also arguably being weighed by disappointing NY Fed Manufacturing data. The regional manufacturing survey index came in at 6.3, below expectations for 13.5 and down from last month’s 10.5, an early signal of a mild deterioration in US manufacturing conditions this month.

NZD/USD set to make a break for fresh multi-year highs

Last week’s high in NZD/USD of 0.6914 looks there for the taking if the pair can manage a break above the psychological 0.6900 level this week. Beyond that level, significant resistance resides in the 0.6940 region (January, February and March 2019 highs), followed by the December 2018 high at 0.6970.

To the downside, significant support resides between 0.6790 and 0.6810; last Friday’s low sits at 0.6810 and below the psychological 0.6800 level are the 2 and 18 September highs at 0.6790 and 0.6798 respectively.

Looking at the pair on a shorter time horizon, Monday’s late Asia/early European session’s double top at 0.6890 ought to provide decent intraday support. Below that, the 0.6850 level seems to have provoked a decent reaction every time it has been reached over the past few days, either acting as decent support or resistance or seeing a surge above or below the level.

NZD/USD

Overview
Today last price0.6896
Today Daily Change0.0048
Today Daily Change %0.70
Today daily open0.6848
 
Trends
Daily SMA200.6713
Daily SMA500.6668
Daily SMA1000.6634
Daily SMA2000.6405
 
Levels
Previous Daily High0.686
Previous Daily Low0.681
Previous Weekly High0.6915
Previous Weekly Low0.6783
Previous Monthly High0.6726
Previous Monthly Low0.6546
Daily Fibonacci 38.2%0.6841
Daily Fibonacci 61.8%0.6829
Daily Pivot Point S10.6819
Daily Pivot Point S20.6789
Daily Pivot Point S30.6769
Daily Pivot Point R10.6869
Daily Pivot Point R20.6889
Daily Pivot Point R30.6919

Author

Joel Frank

Joel Frank

Independent Analyst

Joel Frank is an economics graduate from the University of Birmingham and has worked as a full-time financial market analyst since 2018, specialising in the coverage of how developments in the global economy impact financial asset

More from Joel Frank
Share:

Editor's Picks

EUR/USD tests 1.1800 barrier above 50-day EMA

EUR/USD gains ground after three days of losses, trading around 1.1790 during the Asian hours on Thursday. The 14-day Relative Strength Index momentum indicator at 47 (neutral) reflects easing momentum. The RSI below 50 keeps momentum balanced and could limit follow-through.

GBP/USD struggles near four-week low vs. USD, below 1.3500 amid BoE rate cut bets

The GBP/USD pair is seen consolidating its weekly losses registered over the past three days and oscillating in a narrow range near a four-week trough, touched during the Asians session on Thursday. Spot prices currently trade just below the 1.3500 psychological mark and seem vulnerable to slide further.

Gold consolidates below $5,000 amid geopolitical risk, hawkish FOMC Minutes

Gold extends its sideways consolidative price move through the Asian session on Thursday and remains below the $5,000 psychological mark as traders seem hesitant amid mixed cues. The US Dollar preserves its strong gains to over a one-week high in the wake of somewhat hawkish Minutes of the US Federal Reserve’s January monetary policy meeting. 

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments. The technical outlook suggests further gains if INJ breaks above key resistance.

Mixed UK inflation data no gamechanger for the Bank of England

Food inflation plunged in January, but service sector price pressure is proving stickier. We continue to expect Bank of England rate cuts in March and June. The latest UK inflation read is a mixed bag for the Bank of England, but we doubt it drastically changes the odds of a March rate cut.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments.